Loading insider details...
Beta
Latest Form 4 (May 4, 2026): Conversion of 6,702 SPTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 4, 2026 | Seaport Therapeutics, Inc. (SPTX) | Conversion | 6,702 | n/a |
| Feb 12, 2024 | ImmunoGen, Inc. (IMGN) | Disposition to Issuer | 295,975 | n/a |
| Feb 5, 2024 | ImmunoGen, Inc. (IMGN) | Grant/Award | 19,519 | n/a |
| Aug 31, 2023 | C4 Therapeutics, Inc. (CCCC) | Exercise/Conversion | 2,250 | n/a |
| Feb 15, 2023 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 26,000 | n/a |
| Feb 1, 2023 | C4 Therapeutics, Inc. (CCCC) | Exercise/Conversion | 3,750 | n/a |
| May 27, 2022 | C4 Therapeutics, Inc. (CCCC) | Exercise/Conversion | 3,750 | n/a |
| Feb 16, 2022 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 100,000 | n/a |
| Jun 21, 2021 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 136,000 | n/a |